1. Home
  2. STVN vs CUZ Comparison

STVN vs CUZ Comparison

Compare STVN & CUZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STVN
  • CUZ
  • Stock Information
  • Founded
  • STVN 1949
  • CUZ 1958
  • Country
  • STVN Italy
  • CUZ United States
  • Employees
  • STVN N/A
  • CUZ N/A
  • Industry
  • STVN Containers/Packaging
  • CUZ Real Estate Investment Trusts
  • Sector
  • STVN Consumer Discretionary
  • CUZ Real Estate
  • Exchange
  • STVN Nasdaq
  • CUZ Nasdaq
  • Market Cap
  • STVN 5.7B
  • CUZ 4.9B
  • IPO Year
  • STVN 2021
  • CUZ N/A
  • Fundamental
  • Price
  • STVN $21.77
  • CUZ $27.54
  • Analyst Decision
  • STVN Buy
  • CUZ Buy
  • Analyst Count
  • STVN 6
  • CUZ 9
  • Target Price
  • STVN $25.08
  • CUZ $32.56
  • AVG Volume (30 Days)
  • STVN 338.6K
  • CUZ 1.4M
  • Earning Date
  • STVN 05-08-2025
  • CUZ 05-01-2025
  • Dividend Yield
  • STVN 0.27%
  • CUZ 4.65%
  • EPS Growth
  • STVN N/A
  • CUZ N/A
  • EPS
  • STVN 0.45
  • CUZ 0.30
  • Revenue
  • STVN $1,143,012,735.00
  • CUZ $853,962,000.00
  • Revenue This Year
  • STVN $8.60
  • CUZ $11.57
  • Revenue Next Year
  • STVN $10.43
  • CUZ $4.18
  • P/E Ratio
  • STVN $48.77
  • CUZ $92.18
  • Revenue Growth
  • STVN 1.72
  • CUZ 6.06
  • 52 Week Low
  • STVN $16.56
  • CUZ $22.01
  • 52 Week High
  • STVN $28.77
  • CUZ $32.55
  • Technical
  • Relative Strength Index (RSI)
  • STVN 56.72
  • CUZ 49.31
  • Support Level
  • STVN $21.13
  • CUZ $26.03
  • Resistance Level
  • STVN $22.46
  • CUZ $28.21
  • Average True Range (ATR)
  • STVN 1.33
  • CUZ 1.16
  • MACD
  • STVN 0.12
  • CUZ 0.17
  • Stochastic Oscillator
  • STVN 86.32
  • CUZ 84.54

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

About CUZ Cousins Properties Incorporated

Cousins Properties Inc is a real estate investment trust principally involved in the ownership, management, and development of properties in the Southern United States. Cousins Properties' real estate portfolio mainly comprises offices and mixed-use developments that encompass both apartment and retail space. Offices make up the vast majority of the portfolio in terms of total square footage. The segments operates in following geographical areas: Atlanta, Austin, Charlotte, Dallas, Phoenix, Tampa, and other markets. The company derives nearly all of its revenue in the form of rental income from its properties, the majority of which comes from its office locations. A diverse set of tenants in the cities of Houston and Atlanta represent the company's key markets.

Share on Social Networks: